AURA today
$7.21-$0.40 (-5.26%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourBearish
15 minStrong Bearish
5 minExpanding
Daily trend turns up above $6.77
Key levels
Resistance$8.11
Resistance$7.42
Support$6.66
Support$6.17
Latest news & SEC filings
EarningsAura Biosciences posts smaller Q3 loss than analysts expected
SEC FilingAura Biosciences, Inc. filed a report on a major company event (Form 8-K)
All AURA news →About Aura Biosciences
Aura Biosciences is a biotechnology company that develops targeted therapies for cancer. Its main focus is on creating treatments for primary and metastatic tumors, including ocular melanoma and other cancers. The company operates in the United States and conducts research and clinical trials to advance its product candidates.
Based on the company's 10-K filed Mar 30, 2026.
Nasdaq · Healthcare
Aura Biosciences, Inc. (AURA)
What Is the Price Target for AURA?
SEPT Low Target
$24.00
SEPT Mid Target
$24.00
SEPT High Target
$24.00
Analyst Consensus
$24.00
Is AURA a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AURA.
Start Free Trial →Is AURA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$20.05
12
Moat Score
NONE
1/9
Piotroski Score
1.8
Altman Z-Score
What Is Smart Money Doing with AURA?
Insider Signal
SELLING
0 buys / 8 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Kratz Erica | officer | Buy | 100,885 | - | Sep 1, 2026 |
| Abu-Absi Susan | officer | Buy | 134,513 | - | Sep 1, 2026 |
| Elazzouzi Amy | officer | Buy | 23,540 | - | Sep 1, 2026 |
| Hopkins Janet Jill | officer | Buy | 58,850 | - | Sep 1, 2026 |
| Person Julie | officer | Buy | 107,611 | - | Sep 1, 2026 |
| Bitetti Teresa Marie | director | Buy | 15,000 | - | Jun 11, 2026 |
| Srivastava Sapna | director | Buy | 15,000 | - | Jun 11, 2026 |
| Johnson David Michael | director | Buy | 15,000 | - | Jun 11, 2026 |
| Mattessich Antony C. | director | Buy | 15,000 | - | Jun 11, 2026 |
| Holles Natalie C. | director officer | Buy | 600,118 | - | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AURA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-0.57%
FCF Growth YoY
-5.1%
Revenue Trend
UNKNOWN
Dark Pool Trades for AURA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AURA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:14:00 | $7.19 | 1,400 | $$10K | SELL |
| 15:13:55 | $7.18 | 1,260 | $$9K | SELL |
| 15:09:58 | $7.23 | 1,116 | $$8K | BUY |
| 15:09:15 | $7.23 | 2,300 | $$17K | SELL |
| 15:09:15 | $7.25 | 5,600 | $$41K | MIDPOINT |
5 dark pool trades shown · $$84K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Aura Biosciences, Inc. (AURA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AURA — frequently asked questions
What is AURA stock price today?
Aura Biosciences, Inc. (AURA) is at $7.21, down 5.26% (-$0.40) at the Nov 12, 2026 close.
Why is AURA stock moving today?
Latest AURA news — Nov 9, 2026: Aura Biosciences posts smaller Q3 loss than analysts expected · Nov 9, 2026: Aura Biosciences, Inc. filed a report on a major company event (Form 8-K)
Why did AURA stock move on Nov 9, 2026?
Aura Biosciences shares surged 14.84% to close at $7.66 after the company reported a smaller-than-expected quarterly loss of 29 cents per share, beating the consensus estimate of 37 cents. The stock traded between $6.62 and $7.70 on volume of over 1 million shares, reflecting strong investor reaction to the earnings beat.
What is the AURA price target?
The average analyst price target for AURA is $24.00, ranging from $24 to $24, based on 1 analysts. Latest: HC Wainwright & Co. maintains on Apr 29, 2026.
What do analysts rate AURA?
Analyst ratings for AURA: 6 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did AURA beat earnings?
AURA last reported on Nov 9, 2026: EPS -$0.29 vs -$0.37 expected — a beat of 21.6%.
Does AURA pay a dividend?
AURA does not currently pay a dividend.
What are AURA support and resistance levels?
Support: $6.66, $6.17, $5.38. Resistance: $7.42, $8.11, $8.52.
What are insiders doing with AURA?
Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.
What is the latest news on AURA?
Nov 9, 2026: Aura Biosciences posts smaller Q3 loss than analysts expected · Nov 9, 2026: Aura Biosciences, Inc. filed a report on a major company event (Form 8-K)